Acne Vulgaris Market By Therapeutic Class (Retinoid (Topical Retinoid & Combination Retinoid and Oral Retinoid (Isotretinoin)), Antibiotic (Topical Antibiotic & Combination Antibiotics, and Oral Antibiotics), Salicylic Acid, Benzoyl Peroxide, and Others), By Product (Mask, Creams & Lotions, Cleansers & Toners, and Others), By Formulation (Topical Medication and Oral Medication), By Acne Type (Non-inflammatory acne and Inflammatory acne), By Distribution Channel (Retail Drug Store, Hospital Pharmacies, and E-Commerce), and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Acne Vulgaris Market Size was valued at USD 9.2 billion in 2022 and is poised to grow at a significant CAGR of 5.1% from 2023-2029. Acne vulgaris is a very common chronic skin condition involving blockage or inflammation of the sebaceous gland. It occurs mostly in teenagers and young adults. Pus-filled pimples, inflame, red bumps, and uninflamed blackheads are very common symptoms of acne vulgaris. Treatment includes over-the-counter creams, cleansers, retinoids, antibiotics, salicylic acid, and benzoyl peroxide.

The rising prevalence of acne among teenagers & young adults is driving the global market of acne vulgaris. For instance, according to NCBI, Acne is estimated to affect 9.4% of the global population, making it the eighth most prevalent disease worldwide. Several clinical studies have reported a prevalence of adolescent acne ranging from 81 to 95 percent in young men and 79 to 82 percent in young women. Clinical approval & launch of new drugs are propelling the market growth.  Despite all of the driving factors, some factors are limiting the market growth among them most influential restrain of the market is the side effects of acne treatment drugs. Some medications for acne vulgaris can cause severe allergic reactions, irritations, nausea, vomiting, etc.

Moreover, available treatment options and the introduction of new products for acne treatment such as retinoids, and antibiotics are increasing awareness all over the world. Efficient marketing is expected to propel the market. Also, hormonal therapy has potential growth opportunities in the future. The growing demand for hormonal therapies and recurring investments in the research and development sector for new drugs and therapies will exponentially grow the global acne vulgaris market. North America is dominating the market based on the region due to rising concerns about derma products. 

Acne Vulgaris Market Key Development:
  • In July 2022, Glenmark Pharmaceuticals launched its topical Minocycline 4% gel for the treatment of moderate to severe acne under the brand MINYM.
  • In Mar 2022, Galderma announced the launch of Twyneo (tretinoin 0.1% and benzoyl peroxide 3%) cream for the topical treatment of acne vulgaris in patients 9 years of age and older.

Acne Vulgaris Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.1%

Largest Market

Asia-Pacific

Fastest Growing Market

North America
Acne Vulgaris Market Dynamics

The increasing prevalence of chronic acne accelerated the global market of acne vulgaris. Acne is a highly prevalent skin disorder among teenagers and young adults. According to the Global Burden of Disease (GBD) study, acne vulgaris affects around 85% of teens and young adults aged 12-25 years. With the increase in adult acne conditions, the global acne vulgaris market will grow rapidly in the forecasted years. Acute acne patients are often suffer psychological issues like anxiety, depression, low self-esteem, poor quality of life, and loneliness. According to a Turkish study, it states that patients with acne were at increased risk for anxiety and depression compared to the normal population. The risk of anxiety and depression were 26.2% and 29.5%. These psychological issues are expected to fuel the growth of the global acne vulgaris market.

Acne Vulgaris Market Segmentation

By Therapeutic Class
  • Retinoid
    • Topical Retinoid & Combination Retinoid
    • Oral Retinoid (Isotretinoin)
  • Antibiotic
    • Topical Antibiotic & Combination Antibiotics
    • Oral Antibiotics
  • Salicylic Acid
  • Benzoyl Peroxide
  • Others
By Product Type
  • Mask
  • Creams & Lotions
  • Cleansers & Toners
  • Others
By Distribution Channel
  • Retail Drug Store
  • Hospital Pharmacies
  • E-Commerce

Frequently Asked Questions

The acne vulgaris market is projected to expand at a CAGR of 5.1% during the forecast period

Galderma S.A., Pfizer, Allergan, Botanix pharmaceuticals, Sun Pharmaceutical industry

North America is the fastest-growing region for acne vulgaris market

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1. Executive Summary
2. Global Acne Vulgaris Market Introduction
2.1. Global Acne Vulgaris Market Taxonomy
2.2. Global Acne Vulgaris Market Definitions
2.2.1. By Therapeutic Class
2.2.2. By Product
2.2.3. By Formulation
2.2.4. By Acne Type
2.2.5. By Distribution Channel
2.2.6. By Region
3. Global Acne Vulgaris Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Acne Vulgaris Market Dynamic Factors - Impact Analysis
3.6. Global Acne Vulgaris Market Competition Landscape
3.7. Epidemiology
4. Global Acne Vulgaris Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Acne Vulgaris Market, By Therapeutic Class, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1. Retinoid
5.1.1. Topical Retinoid & Combination Retinoid
5.1.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Oral Retinoid (Isotretinoin)
5.1.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.2. Antibiotic
5.2.1. Topical Antibiotic & Combination Antibiotics
5.2.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Oral Antibiotics
5.2.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.3. Salicylic Acid
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Benzoyl Peroxide
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Acne Vulgaris Market, By Product, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1. Mask
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Creams & Lotions
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Cleansers & Toners
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Acne Vulgaris Market, By Formulation, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1. Topical Medication
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Oral Medication
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Acne Vulgaris Market, By Acne Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1. Non-inflammatory acne
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Inflammatory acne
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
9. Global Acne Vulgaris Market, By Acne Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1. Retail Drug Store
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Hospital Pharmacies
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. E-Commerce
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
10. Global Acne Vulgaris Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1. North America
10.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Acne Vulgaris Market - Opportunity Analysis Index, By Therapeutic Class, By Product, By Formulation, By Acne Type, By distribution Channel and Region, 2023 - 2029
11. North America Acne Vulgaris Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. Therapeutic Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Retinoid
11.1.1.1. Topical Retinoid & Combination Retinoid
11.1.1.2. Oral Retinoid (Isotretinoin)
11.1.2. Antibiotic
11.1.2.1. Topical Antibiotic & Combination Antibiotics
11.1.2.2. Oral Antibiotics
11.1.3. Salicylic Acid
11.1.4. Benzoyl Peroxide
11.1.5. Others
11.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Mask
11.2.2. Creams & Lotions
11.2.3. Cleansers & Toners
11.2.4. Others
11.3. Formulation Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Topical Medication
11.3.2. Oral Medication
11.4. Acne Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Non-inflammatory acne
11.4.2. Inflammatory acne
11.5. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Retail Drug Store
11.5.2. Hospital Pharmacies
11.5.3. E-Commerce
11.6. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.6.1. USA
11.6.2. Canada
11.7. North America Acne Vulgaris Market - Opportunity Analysis Index, By Therapeutic Class, By Product, By Formulation, By Acne Type, By Distribution Channel and Country, 2023 - 2029
11.8. North America Acne Vulgaris Market Dynamics Trends
12. Europe Acne Vulgaris Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Therapeutic Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Retinoid
12.1.1.1. Topical Retinoid & Combination Retinoid
12.1.1.2. Oral Retinoid (Isotretinoin)
12.1.2. Antibiotic
12.1.2.1. Topical Antibiotic & Combination Antibiotics
12.1.2.2. Oral Antibiotics
12.1.3. Salicylic Acid
12.1.4. Benzoyl Peroxide
12.1.5. Others
12.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Mask
12.2.2. Creams & Lotions
12.2.3. Cleansers & Toners
12.2.4. Others
12.3. Formulation Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Topical Medication
12.3.2. Oral Medication
12.4. Acne Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Non-inflammatory acne
12.4.2. Inflammatory acne
12.5. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.5.1. Retail Drug Store
12.5.2. Hospital Pharmacies
12.5.3. E-Commerce
12.6. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Acne Vulgaris Market - Opportunity Analysis Index, By Therapeutic Class, By Product, By Formulation, By Acne Type, By Distribution Channel and Country, 2023 - 2029
12.8. Europe Acne Vulgaris Market Dynamics Trends
13. Asia-Pacific Acne Vulgaris Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.1. Therapeutic Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Retinoid
13.1.1.1. Topical Retinoid & Combination Retinoid
13.1.1.2. Oral Retinoid (Isotretinoin)
13.1.2. Antibiotic
13.1.2.1. Topical Antibiotic & Combination Antibiotics
13.1.2.2. Oral Antibiotics
13.1.3. Salicylic Acid
13.1.4. Benzoyl Peroxide
13.1.5. Others
13.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Mask
13.2.2. Creams & Lotions
13.2.3. Cleansers & Toners
13.2.4. Others
13.3. Formulation Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Topical Medication
13.3.2. Oral Medication
13.4. Acne Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Non-inflammatory acne
13.4.2. Inflammatory acne
13.5. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Retail Drug Store
13.5.2. Hospital Pharmacies
13.5.3. E-Commerce
13.6. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. ASEAN
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia-Pacific
13.7. Asia-Pacific Acne Vulgaris Market - Opportunity Analysis Index, By Therapeutic Class, By Product, By Formulation, By Acne Type, By Distribution Channel and Country, 2023 - 2029
13.8. Asia-Pacific Acne Vulgaris Market Dynamics Trends
14. Latin America Acne Vulgaris Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
14.1. Therapeutic Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Retinoid
14.1.1.1. Topical Retinoid & Combination Retinoid
14.1.1.2. Oral Retinoid (Isotretinoin)
14.1.2. Antibiotic
14.1.2.1. Topical Antibiotic & Combination Antibiotics
14.1.2.2. Oral Antibiotics
14.1.3. Salicylic Acid
14.1.4. Benzoyl Peroxide
14.1.5. Others
14.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Mask
14.2.2. Creams & Lotions
14.2.3. Cleansers & Toners
14.2.4. Others
14.3. Formulation Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Topical Medication
14.3.2. Oral Medication
14.4. Acne Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Non-inflammatory acne
14.4.2. Inflammatory acne
14.5. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.5.1. Retail Drug Store
14.5.2. Hospital Pharmacies
14.5.3. E-Commerce
14.6. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Acne Vulgaris Market - Opportunity Analysis Index, By Therapeutic Class, By Product, By Formulation, By Acne Type, By Distribution Channel and Country, 2023 - 2029
14.8. Latin America Acne Vulgaris Market Dynamics Trends
15. Middle East and Africa Acne Vulgaris Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
15.1. Therapeutic Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.1.1. Retinoid
15.1.1.1. Topical Retinoid & Combination Retinoid
15.1.1.2. Oral Retinoid (Isotretinoin)
15.1.2. Antibiotic
15.1.2.1. Topical Antibiotic & Combination Antibiotics
15.1.2.2. Oral Antibiotics
15.1.3. Salicylic Acid
15.1.4. Benzoyl Peroxide
15.1.5. Others
15.2. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.2.1. Mask
15.2.2. Creams & Lotions
15.2.3. Cleansers & Toners
15.2.4. Others
15.3. Formulation Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Topical Medication
15.3.2. Oral Medication
15.4. Acne Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.4.1. Non-inflammatory acne
15.4.2. Inflammatory acne
15.5. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.5.1. Retail Drug Store
15.5.2. Hospital Pharmacies
15.5.3. E-Commerce
15.6. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
15.6.1. Gulf Cooperation Council (GCC) Countries
15.6.2. South Africa
15.6.3. Rest of MEA
15.7. MEA Acne Vulgaris Market - Opportunity Analysis Index, By Therapeutic Class, By Product, By Formulation, By Acne Type, By Distribution Channel and Country, 2023 - 2029
15.8. MEA Acne Vulgaris Market Dynamics Trends
16. Competition Landscape
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Key Therapeutic Classes, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Galderma S.A.
16.2.2. Pfizer
16.2.3. Allergan
16.2.4. Botanix pharmaceuticals
16.2.5. Sun Pharmaceutical industry
16.2.6. GlaxoSmithKline
16.2.7. Alembic Pharmaceuticals
16.2.8. Almirall, S.A
16.2.9. Johnson & Johnson
16.2.10. Bausch Health Companies
16.2.11. Teva Pharmaceutical Industries Ltd.
16.2.12. Candela Medical
17. Research Methodology
18. Key Assumptions and Acronyms
  • Galderma S.A.
  • Pfizer
  • Allergan
  • Botanix pharmaceuticals
  • Sun Pharmaceutical industry
  • GlaxoSmithKline
  • Alembic Pharmaceuticals
  • Almirall, S.A
  • Johnson & Johnson
  • Bausch Health Companies
  • Teva Pharmaceutical Industries Ltd.
  • Candela Medical

Adjacent Markets